Welcome to our dedicated page for MSP Recovery SEC filings (Ticker: MSPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MSP Recovery's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MSP Recovery's regulatory disclosures and financial reporting.
MSP Recovery, Inc. entered a material letter agreement with Hazel Partners Holdings LLC, its lender under an existing working capital credit facility, for a one-time advance of $0.2 million on June 26, 2026. The funding is to be used primarily for operating expenses and was provided under Hazel’s discretionary “Operational Collection Floor” mechanism.
The company previously disclosed aggregate advances of about $6.0 million under this mechanism, with no remaining capacity. This new advance temporarily increases that floor but is described as a standalone accommodation that does not reinstate or reopen availability under the facility. MSP Recovery states that aside from this specific amount, no additional funding is available, and it has no rights to or reasonable basis to expect further advances from Hazel.
The company emphasizes that the $0.2 million advance does not change the discretionary nature of the credit facility or provide ongoing or recurring liquidity, and cautions that it should not be viewed as evidence of future funding or the company’s ability to meet operating or debt service obligations beyond this limited support.
MSP Recovery, Inc. amends its prospectus to register up to 909,982 shares of Class A Common Stock for resale by selling securityholders and to register up to 755,200,000 warrants and up to 236,019 shares issuable upon exercise of warrants.
The supplement gives effect to a 1-for-7 reverse stock split effective September 1, 2025 and discloses market closing prices on June 17, 2026. Separately, the company received a $0.1 million one‑time discretionary advance from Hazel Partners Holdings LLC under its working capital credit facility; aggregate prior advances under that discretionary mechanism had reached $6.0 million.
MSP Recovery, Inc. filed Prospectus Supplement No. 64 registering 285,715 shares of Class A Common Stock for resale by YA II PN, Ltd. (Yorkville) under a Standby Equity Purchase Agreement (Yorkville SEPA). The SEPA contemplates up to $250 million of purchases subject to a 9.99% Ownership Limitation and earlier Exchange Cap mechanics. The supplement updates prior terms and attaches a Form 8-K describing a separate $0.1 million discretionary advance from Hazel Partners under the working capital facility. The prospectus states the Company will not receive proceeds from resales by Yorkville, while sales the Company elects to make to Yorkville under the SEPA could generate proceeds to the Company.
MSP Recovery, Inc. files a prospectus supplement registering 32,220 shares of Class A common stock for resale by selling securityholders, including up to 15,239 shares issuable upon exercise of a warrant (the CPIA Warrant). The CPIA Warrant exercise price is $0.4375 per share, so exercise would produce only nominal proceeds to the company.
The supplement attaches a Form 8-K disclosing a one-time $0.1 million discretionary advance from Hazel Partners Holdings LLC under the company’s working capital credit facility and notes that the facility remains discretionary with no committed availability. The company effected a 1-for-7 reverse stock split effective September 1, 2025.
MSP Recovery, Inc. files Prospectus Supplement No. 51 to register 56,896 shares of Class A Common Stock for resale by selling securityholders, including warrants exercisable into shares and shares issued for services. The supplement reflects a 1-for-7 reverse stock split effective September 1, 2025.
The prospectus lists (i) up to 28,572 shares issuable on exercise of VRM Warrants, (ii) 2,858 shares issued to VRP plus up to 14,286 shares issuable on a VRP Warrant, and (iii) 11,180 shares issued to Palantir. Exercise price for VRM and VRP warrants is $0.0175 per share. The supplement attaches the Company’s Form 8-K disclosing a one-time $0.1 million advance from Hazel under a discretionary working capital mechanism; prior advances under that mechanism totaled approximately $6.0 million.
MSP Recovery, Inc. entered into a Hazel Letter Agreement under its existing working capital credit facility, through which Hazel Partners Holdings LLC agreed in its sole discretion to make a one-time $0.1 million advance primarily for operating expenses. This increases prior advances under the facility’s Operational Collection Floor, which had previously totaled about $6.0 million.
The company emphasizes that this advance is a standalone accommodation and does not reinstate or reopen availability under the facility. Other than this specific amount, no additional funding is available, and Hazel has no commitment to provide future advances. MSP Recovery cautions that the receipt of this $0.1 million should not be seen as evidence of future funding or of its ability to meet ongoing operating or debt service obligations.
MSP Recovery, Inc. files a prospectus supplement registering up to 909,982 shares of Class A Common Stock, up to 755,200,000 warrants, and up to 236,019 shares underlying warrants, adjusted for a 1-for-7 reverse stock split.
The supplement attaches a Form 8-K describing short-term funding: a one-time $0.1 million advance from Hazel Partners Holdings, LLC and two one-time accommodations from VRM MSP Recovery Partners, LLC totaling $0.12 million (a $0.06 million advance plus retention of $0.06 million). The company cautions these are standalone, discretionary advances and do not reopen committed availability under its working capital credit facility.
MSP Recovery, Inc. registers 285,715 shares of Class A Common Stock for resale by a selling securityholder under a prospectus supplement dated June 4, 2026. The shares relate to issuances tied to the Yorkville SEPA, under which the Company may issue up to $250 million of Class A Common Stock to YA II PN, Ltd., subject to an Ownership Limitation (9.99%) and the previously applicable Exchange Cap.
The prospectus states that the Company will not receive proceeds from sales by Yorkville under this prospectus, although the Company may receive proceeds if it elects to sell shares to Yorkville under the Yorkville SEPA. The Yorkville arrangement also includes Convertible Notes with an aggregate principal of $15.75 million and conversion mechanics tied to specified fixed prices and a VWAP floor of $0.50. The filing discloses multiple Floor Price reductions culminating in a $0.50 Floor Price, the Company’s Nasdaq delisting and transfer to the OTCQB, and reported closing Common Stock price of $0.0269 on June 3, 2026.
MSP Recovery, Inc. registers 32,220 shares of Class A Common Stock for resale by selling securityholders, including up to 15,239 shares issuable upon exercise of the CPIA Warrant.
The prospectus supplement attaches a Form 8-K that discloses short-term funding arrangements: a $0.1 million one-time advance from Hazel Partners (made May 29, 2026) and two VRM arrangements permitting a $0.06 million advance and a $0.06 million retention of recovery proceeds. The CPIA Warrant exercise price is $0.4375 per share and would yield only nominal proceeds to the company if exercised.
MSP Recovery, Inc. is amending its October 4, 2024 prospectus to register up to 56,896 shares of Class A Common Stock for resale by selling securityholders. The registered shares include 28,572 shares issuable upon exercise of VRM Warrants, 2,858 shares issued to VRP plus 14,286 issuable under a VRP Warrant, and 11,180 shares issued as consideration to Palantir Technologies, Inc.
The supplement attaches a Form 8-K reporting May 29, 2026 letter agreements: a Hazel one-time advance of $0.1 million, VRM one-time advance of $0.06 million and a permitted retention of $0.06 million of recovery proceeds. The supplement notes a 1-for-7 reverse split effective September 1, 2025; share and per-share figures are adjusted accordingly.